Skip to content

MNPR - Monopar Therapeutics - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchM

Monopar Therapeutics Inc

MNPR · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

M

MNPRMonopar Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $124.82
52-wk low: $29.18
Prev close: $84.70
Mkt cap: $831.2M
Beta: 1.51
P/B: 6.1x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$67.2M

BA
Balyasny
Dmitry Balyasny · Q2 2026 13F
$12.5M
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Reported Aug 11, 2026

Earnings came in 7.5% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $831M

Valuation

P/B6.12

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: MNPR
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $831.24M
Beta: 1.51

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-19.5%

$4.7M

position

WC

Walleye Capital

Q1 2026 13F

$3.5M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for MNPR

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.62+7.5%

-$0.67 expected

Next report

What the street expects next

EPS expected

-$0.84

-$1.37 to -$0.37

Revenue expected

$0.00

11 analysts

Last 30 days

6up1down

Analysts raising estimates

Estimate drift

0.07

Change in 30 days

-19.5%

ROA-14.6%

Growth

Beta1.51